Olopatadine Hydrochloride
Pricing Report NDC 61314-272-25

Latest NADAC: $4.43280 per ML · Effective Sep 22, 2021 · Est. package price $11.08 (2.5 ML)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Olopatadine Hydrochloride (NDC 61314-272-25) is $4.43280 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 22, 2021.

As a provided by Sandoz Inc, this medication is distributed in a 1 BOTTLE, DROPPER in 1 CARTON / 2.5 mL in 1 BOTTLE, DROPPER configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$4.43280
Per ML

Effective Date
Sep 22, 2021
Billable Units
2.5 ML
Estimated Package Price
$11.08
Data Status
As of Sep 29, 2021
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE, DROPPER in 1 CARTON / 2.5 mL in 1 BOTTLE, DROPPER
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2017, the NADAC wholesale price for (NDC ) has moved within a range of $4.24766 to $48.01587 per ML. Over this 4 years period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$4.2477 - $48.0159
Market Volatility
1,030.41% Variance
Latest Trend
4.36%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 22, 2021 $4.43280 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 18, 2021 $4.24766 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 21, 2021 $4.30224 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 23, 2021 $5.86212 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 19, 2021 $4.79188 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 21, 2021 $4.70013 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 17, 2021 $4.93047 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 17, 2021 $5.11115 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 20, 2021 $5.29724 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 23, 2020 $5.15125 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 18, 2020 $5.03793 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 21, 2020 $4.88212 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026